SCHEMBL690595

SCHEMBL690595

CN(c1ccccc1)c1cc(Nc2cccc(NC(=O)O)c2)ncn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 5/20 0.55
TNNI3K Q59H18 3/20 0.55
PIP4K2A P48426 4/20 0.46
PIP4K2B P78356 4/20 0.46
SCN9A Q15858 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CLK4 Q9HAZ1 1/20 0.44
ERBB3 P21860 1/20 0.44
LCK P06239 3/20 0.43
TUBB4A P04350 1/20 0.43
TUBB P07437 1/20 0.43
TUBA3C P0DPH7 1/20 0.43
TUBA1B P68363 1/20 0.43
TUBA4A P68366 1/20 0.43
TUBB4B P68371 1/20 0.43
TUBB3 Q13509 1/20 0.43
TUBB2A Q13885 1/20 0.43
TUBB8 Q3ZCM7 1/20 0.43
TUBA3E Q6PEY2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL690944 0.88 EGFR (0.61) EGFRTNNI3KPIP4K2APIP4K2BBTK
SCHEMBL691467 0.86 EGFR (0.47) EGFRTNNI3KPIP4K2APIP4K2BSCN9A
SCHEMBL413659 0.85 TNNI3K (0.54) EGFRTNNI3KCYP1A2CYP2C9CLK4
SCHEMBL2778932 0.81 EGFR (0.53) EGFRTNNI3KCYP1A2CYP2C9CLK4
SCHEMBL690055 0.77 EGFR (0.53) EGFRTNNI3KCYP1A2CYP2C9CLK4
SCHEMBL1243031 0.76 EGFR (0.51) EGFRERBB3TUBB4ATUBBTUBA3C
SCHEMBL13777940 0.75 EGFR (0.74) EGFRLCKTUBB4ATUBBTUBA3C
SCHEMBL17856981 0.73 FGFR4 (0.62) EGFRPIP4K2APIP4K2BLCKBTK
SCHEMBL13777945 0.73 EGFR (0.74) EGFRLCKTUBB4ATUBBTUBA3C
SCHEMBL11317380 0.72 MEN1 (0.55) EGFRTNNI3KCYP1A2CYP2C9CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421538-A1 HETEROARYL COMPOUNDS AND USES THEREOF Avila Therapeutics, Inc. (US) 2012-02-29 EP disclosed
WO-2010123870-A1 HETEROARYL COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2010-10-28 WO disclosed